Knight Therapeutics Inc.
Knight Therapeutics Inc., a prominent Canadian biopharmaceutical company, is headquartered in Montreal, Quebec. Founded in 2014, Knight Therapeutics focuses on the acquisition, development, and commercialisation of innovative pharmaceutical products, primarily in the areas of oncology, infectious diseases, and rare diseases. With a commitment to addressing unmet medical needs, the company has established a strong market position through strategic partnerships and a robust pipeline of unique therapies. Knight Therapeutics is recognised for its dedication to patient-centric solutions, offering a range of products that stand out for their efficacy and safety profiles. As a leader in the biopharmaceutical industry, Knight Therapeutics continues to make significant strides in improving health outcomes across Canada and beyond.
DitchCarbon Score
How does Knight Therapeutics Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Knight Therapeutics Inc.'s score of 13 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Knight Therapeutics Inc.'s reported carbon emissions
Knight Therapeutics Inc., headquartered in Canada, currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is important to note that many companies in the pharmaceutical sector are increasingly focusing on sustainability and climate commitments. This includes setting science-based targets and engaging in initiatives aimed at reducing their carbon footprint. As Knight Therapeutics Inc. continues to navigate the evolving landscape of corporate responsibility, future commitments may emerge to align with industry standards for climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Knight Therapeutics Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
